Yuen Wo Tsang

Chief Tech/Sci/R&D Officer at WAI YUEN TONG MEDICINE HOLDINGS LIMITED

Consumer Services

Health Technology

Commercial Services

Profile

Yuen Wo Tsang is currently the Director-Technical at Wai Yuen Tong Medicine Holdings Ltd.
and also holds the position of Technical Director at Luxembourg Institute of Health.
Dr. Tsang has a graduate degree from The University of Sydney and an undergraduate degree from the University of Aston.

Yuen Wo Tsang active positions

Companies	Position	Start
WAI YUEN TONG MEDICINE HOLDINGS LIMITED	Chief Tech/Sci/R&D Officer	2018-08-31
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Chief Tech/Sci/R&D Officer	-

All active positions of Yuen Wo Tsang

Training of Yuen Wo Tsang

The University of Sydney	Graduate Degree
University of Aston	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yuen Wo Tsang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
WAI YUEN TONG MEDICINE HOLDINGS LIMITED	Health Technology

Private companies	1
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Commercial Services